NCT00409721View on ClinicalTrials.gov

The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis (ALS)

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG

Memantine

Trial Locations (2)

T2N 4N1

Calgary ALS Neuromuscular Clinic, Calgary

T6G 2B7

University of Alberta ALS Clinic, Edmonton

All Listed Sponsors
collaborator

ALS Association

OTHER

lead

University of Alberta

OTHER

NCT00409721 - The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis (ALS) | Biotech Hunter | Biotech Hunter